BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1 pandemic.
Wikipage redirect
primaryTopic
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1 pandemic.
has abstract
BioCryst Pharmaceuticals, Inc. ...... A virus subtype H1N1 pandemic.
@en
バイオクリスト(BioCryst Pharmaceuticals)は、アラバマ州バーミングハムに本社を置く製薬会社である。癌、自己免疫疾患、ウイルス感染の薬を作っている。
@ja
assets ($)
equity ($)
founding year
industry
location
net income ($)
number of employees
operating income ($)
product
revenue ($)
type
Link from a Wikipage to an external page
Wikipage page ID
22,617,127
Wikipage revision ID
739,018,583
subject
comment
BioCryst Pharmaceuticals, Inc. ...... A virus subtype H1N1 pandemic.
@en
バイオクリスト(BioCryst Pharmaceuticals)は、アラバマ州バーミングハムに本社を置く製薬会社である。癌、自己免疫疾患、ウイルス感染の薬を作っている。
@ja
label
BioCryst Pharmaceuticals
@en
バイオクリスト
@ja
wasDerivedFrom
homepage
isPrimaryTopicOf
name
BioCryst Pharmaceuticals, Inc.
@en